2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$7.16+$0.010 (+0.14%)
Price as of Aug 24, 2026 8:52 AM EDT- $66.4MMarket Cap
- -23.20%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$7.16+$0.010 (+0.14%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.15 | ||
Change | +$0.11 (+1.56%) | ||
Open | $8.01 | ||
High | $8.01 | ||
Low | $7.08 | ||
Previous Close | $7.04 | ||
Volume | 10,232 | ||
30-Day Average Volume | 6,561 | ||
1-Week Change | 22.85% | ||
1-Month Change | 34.27% | ||
1-Year Change | -23.20% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $8.0M | ||
Market Cap | $66.4M | ||
Enterprise Value | $60.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $76,949.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | 789 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 18 | ||
P/E | -22 | ||
PEG | 1 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue